Keyphrases
Inflammatory Bowel Disease
64%
Mucosal Gene Expression
32%
Gut Diseases
32%
Inflammation
32%
Cell Ratio
32%
Gene Expression Level
32%
Single-cell Gene Expression
32%
Gut mucosa
32%
Dissociation
32%
Intestinal Transplantation
32%
Graft Rejection
32%
Intestinal Graft
32%
Biological Therapy
32%
Gut Metabolome
32%
Predictive Value
32%
Gut Microbiome
32%
Microbiome
24%
Single-cell RNA Sequencing (scRNA-seq)
22%
Mucosal Biopsy
19%
Cryopreserved
19%
Vedolizumab
18%
Treatment Response
16%
Fecal Metabolites
16%
Thrombophilia Genes
12%
Batch Effects
12%
Collagenase
12%
Protease Digestion
12%
Cell Viability
12%
Severe Complications
10%
Adult Recipients
10%
Intestinal Failure
10%
Patient Cohort
10%
Transplantation
10%
Pediatric Donor
10%
Small Patients
10%
Graft Failure
10%
Expert-based
10%
Parenteral nutrition
10%
Intensive Immunosuppressive Therapy
10%
Acute Cellular Rejection
10%
Clinical Care
10%
Head-to-head Comparison
10%
Treatment Strategy
10%
Infliximab
10%
Adverse Drug Response
9%
Predictive Biomarker
8%
Biological Treatment
8%
Ustekinumab
8%
Large Sample Size
8%
Microbial Profile
8%
Medicine and Dentistry
Gut
100%
Inflammatory Bowel Disease
72%
Gene Expression
67%
RNA Sequence
41%
Genetic Variability
38%
Genetic Background
35%
Genome Wide Association Study
35%
Thrombosis
32%
Biopsy
32%
Enteropathy
32%
Liver Transplantation
32%
Mucosa
32%
Graft Rejection
32%
Intestine Graft
32%
Biological Product
32%
Intestinal Transplantation
32%
Disease
23%
Collagenase
19%
Pediatrics
14%
Proteinase
12%
Cell Viability
12%
Thrombophilia
12%
Parenteral Nutrition
10%
Infliximab
10%
Immunosuppressive Treatment
10%
Graft Failure
10%
Vedolizumab
10%
Acute Graft Rejection
10%
Intestinal Failure
10%
Coeliac Disease
8%
Pathophysiology
8%
Digestive System
8%
Cell Population
8%
Colorectal Carcinoma
8%
Bacilli
6%
Protein Function
6%
Epithelial Cell
6%
Drug Therapy
6%
Glial Cells
6%
Organoid
6%
Fluorescence Activated Cell Sorting
6%
Flow Cytometry
6%
Genetic Risk
6%
Medical Procedures
6%
Intraepithelial Lymphocyte
6%
Immunology and Microbiology
Inflammatory Bowel Disease
80%
RNA Sequence
69%
Gene Expression
40%
Mucosa
36%
Metabolome
32%
Gut Microbiome
32%
Gene Expression Level
32%
Genetic Variation
32%
Microbiome
24%
Expression Quantitative Trait Loci
18%
Cell Population
16%
Sample Size
16%
Digestive System
16%
Cell Viability
16%
Coeliac Disease
16%
Single Nucleotide Polymorphism
9%
Immunocompetent Cell
9%
Intraepithelial Lymphocyte
8%
Cell Count
8%
Metabolite
8%
Bacilli
8%
Organoid
8%
Ustekinumab
8%
Metagenomics
8%
Vedolizumab
8%
Biological Product
8%
Fluorescence Activated Cell Sorting
8%
